Premium
Strategies for the Detection of Disease Genes in Pancreatic Cancer
Author(s) -
WALLRARR C.,
MÜLLERPILLASCH F.,
MICHA A.,
WENGER C.,
GENG M.,
SOLINASTOLDO S.,
LICHTER P.,
FROHME M.,
HOHEISEL J.D.,
ADLER G.,
GRESSA T. M.
Publication year - 1999
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.1999.tb09516.x
Subject(s) - pancreatic cancer , gene , biology , comparative genomic hybridization , suppressor , identification (biology) , complementary dna , representational difference analysis , cancer , genetics , computational biology , cancer research , genome , botany
A bstract : The present review summarizes our strategies aimed at identifying and characterizing genetic alterations occurring at the transcriptional and chromosomal level in pancreatic cancer. To study trancriptional alterations we have used a number of techniques including modified versions of differential hybridizations and cDNA RDA (representational difference analysis). These approaches have led to the identification of more than 500 genes with differen tial expression in pancreatic cancer. To study chromosomal aberrations occurring in pancreatic cancer tissues we used comparative genomic hybridization (CGH). This allowed the identification of a number of chromosomal regions containing putative tumor suppressor genes or oncogenes. Genes isolated in both approaches represent potential new disease genes for pancreatic cancer and are at present being characterized by individual or serial analysis.